Effects of prolonged-release fampridine on multiple sclerosis-related gait impairments. A crossover, double-blinded, placebo-controlled study
Article in Clinical Biomechanics (May 2021)
The most recent citing publications are shown below. View all 16 publications that cite this research output on Dimensions.
A cross-sectional comparison of performance, neurophysiological and MRI outcomes of responders and non-responders to fampridine treatment in multiple sclerosis – An explorative study
Article in Journal of Clinical Neuroscience (November 2020)
Clinical assessment, management, and rehabilitation of walking impairment in MS: an expert review
Article in Expert Review of Neurotherapeutics (August 2020)